Immune checkpoint and other receptor-ligand pairs modulating macrophages in cancer: present and prospects

HIGHLIGHTS

• who: Yuanyuan Yang and colleagues from the Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China have published the research work: Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects, in the Journal: Cancers 2022, 14, 5963. of /2022/
• what: This review summarizes the immune checkpoint and other receptor-ligand interaction between macrophages and tumor cells, which plays an indispensable role in anti-tumor immunity or pro-tumor immunity, such as SIRPu03b1-CD47, PD1-PD-L1, Fcu03b3R-Antibody-Antigen, CSF-1/CSF . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.